624734-17-4

Usage

Uses

Used in Food and Beverage Industry:
3-methoxy-tetrahydropyran-4-one is used as a flavoring agent for its sweet, fruity taste, enhancing the taste of various food and beverage products.
Used in Perfumery and Cosmetics Industry:
3-methoxy-tetrahydropyran-4-one is used as a fragrance ingredient for its pleasant, fruity scent, contributing to the creation of perfumes, cosmetics, and other consumer products.
Used in Traditional Medicine:
3-methoxy-tetrahydropyran-4-one is used as a mild sedative for its calming properties, helping to alleviate stress and anxiety in traditional medicine practices.
Used in Pharmaceutical Industry:
3-methoxy-tetrahydropyran-4-one is used as a precursor in the synthesis of various pharmaceutical compounds, making it a valuable chemical in the development of new medications.

Upstream product

• 104681-92-7 4,4-dimethoxytetrahydro-2H-pyran-3-ol 
• 74-88-4 methyl iodide 
• 624734-16-3 C₈H₁₆O₄ 

Downstream Products

• 624733-88-6 MK₀₈₁₂ 
• 624733-89-7 C₂₄H₃₄F₃N₃O₃ 
• 624733-89-7 C₂₄H₃₄F₃N₃O₃ 
• 624733-89-7 C₂₄H₃₄F₃N₃O₃ 
• 625127-43-7 C₂₂H₃₃NO₄ 
• 1416177-72-4 C₂₃H₃₃N₃O₃ 
• 1416177-73-5 C₂₃H₃₂ClN₃O₃ 
• 1416177-74-6 C₂₃H₃₂BrN₃O₃ 
• 1416177-75-7 C₂₄H₃₂F₃N₃O₃ 
• 1416177-76-8 C₂₃H₃₂N₄O₅ 
• 1416177-77-9 C₂₄H₃₅N₃O₄ 
• 1416177-78-0 C₂₆H₃₉N₃O₄ 
• 1416177-79-1 C₂₄H₃₃FN₂O₃ 
• 1416177-80-4 C₂₄H₃₃ClN₂O₃ 

Relevant academic research and scientific papers

CHEMOKING RECEPTOR ANTAGONISTS

Disclosed herein are chemokine receptor antagonists of formula (I) wherein G1, X1, X2, and X3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

TETRAHYDROPYRAN HETEROCYCLIC CYCLOPENTYL HETEROARYL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is further directed to compounds of the formulas: (I) (II) (wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R15, R16, R17, R18, R19, R24 and R25 are as defined herein) which are modulators of chemokine receptor activity and are useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which chemokine receptors are involved.

TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROISOQUINOLINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of the formula I: I(wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n and the dashed line are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of the formula (I): (wherein R3 et R8 are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.